Bill > SB620

This bill introduces several key provisions related to hemp manufacturing and regulation in Hawaii. The Department of Health will be required to construct, operate, and maintain a state-funded hemp manufacturing facility, and will need to periodically report to the legislature about the facility's funding needs. The bill mandates that hemp processors update their information with the department within 60 days of any changes and prohibits the sale of hemp biomass (including leaves and floral material) directly to consumers. It also imposes new restrictions on orally consumable hemp products, specifying that they must be in the form of tablets, capsules, powders, softgels, gummies, or liquid measured in drops. Additionally, the bill establishes comprehensive labeling requirements for manufactured hemp products, including listing ingredients, manufacturer information, a FDA disclaimer, and the percentage of Hawaii-grown hemp. The bill defines a "gummy" as a gelatinous cube, sphere, prismatoid, or ovoid, and includes an appropriation for the hemp manufacturing facility for fiscal years 2025-2026 and 2026-2027. The new regulations will take effect on July 1, 2025, and aim to provide more oversight and consumer protection in the hemp product industry.

Health and Social Services

https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=SB&billnumber=620&year=2026